Blog
RSS FeedPosted by Michael Wonder on 17 Jan 2020
France removes state funding for dementia drugs
17 January 2020 - The first country in Europe to act on concerns over limited effectiveness. ...
Posted by Michael Wonder on 06 Dec 2019
As Trump looks overseas for drug pricing ideas, one expert says France has some useful approaches
3 December 2019 - As the U.S. grapples with rising costs for prescription medicines, the Trump administration has floated a proposal ...
Posted by Michael Wonder on 03 Dec 2019
Could or should we use MCDA in the French HTA process?
3 December 2019 - Over the last decade, an increasing literature has been highlighting the benefits of introducing multi-criteria decision analysis ...
Posted by Michael Wonder on 20 Nov 2019
French Authorities approve national reimbursement of Orkambi (lumacaftor/ivacaftor) for eligible people ages two and older with cystic fibrosis
20 November 2019 - Vertex Pharmaceuticals today announced that the French Authorities (Comité économique des produits de santé, or CEPS) ...
Posted by Michael Wonder on 01 May 2019
The French solution to US drug prices
30 April 2019 - In June 1974, I rented a room in a lovely bungalow in the village of Vallauris in ...
Posted by Michael Wonder on 16 Dec 2018
Transparency Commission publishes its opinion for Kymriah
14 December 2018 - Opinion published following an examination of written submissions on 12 December 2018. ...
Posted by Michael Wonder on 09 Dec 2018
Transparency Commission publishes its opinion for Yescarta
7 December 2018 - Opinion published following an examination of written submissions on 5 December 2018. ...
Posted by Michael Wonder on 17 Oct 2018
Lojuxta to be reimbursed in France
17 October 2018 - Amryt's lead commercial product now available in all five of the EU's largest markets ...
Posted by Michael Wonder on 03 Oct 2018
Axumin (fluciclovine (18F)) receives positive recommendation from Transparency Committee of the French HAS for use in PET imaging of suspected recurrent prostate cancer
2 October 2018 - Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced that the Transparency Committee of ...
Posted by Michael Wonder on 03 Sep 2018
Agenda for September 5 TC meeting
3 September 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 06 Jul 2018
Agenda for July 11 TC meeting
5 July 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 24 Jun 2018
Agenda for June 27 TC meeting
22 June 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 13 May 2018
Agenda for 16 May TC meeting
11 May 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 30 Apr 2018
A new incentive to encourage the prescription of biosimilars
26 April 2018 - The Directorate General of Health Care Supply and the Directorate General of Social Security published a ...
Posted by Michael Wonder on 12 Apr 2018
Agenda for April 18 meeting
12 April 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...